<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

3 min read

Q419/FY19 US Hemostats and Sealants Market Recap: Solid Growth

4/10/20 10:18 AM

Q419 Hemo and Sealants Header WHITEThe US market for Hemostats and Sealants grew +5.8% YoY in Q419, comparable to its +6.2% growth in Q319, with continued strength in fibrin sealants and good growth in absorbable hemostats.

As reported in SmartTRAK Financial Dashboard, the US Hemostats and Sealants market maintained a solid growth rate of +5.8% in Q419 and grew +5.7% YoY. Leading the way in Q419 was Becton Dickinson (BD),  as its relaunch of Progel continued its resurgence. Baxter also posted strong gains.

Among the many topics covered in the comprehensive Q419/FY19 US Hemostats and Sealants Market Recap* are:

  • Complete Market Overview
  • Company Revenues and Shares
  • Baxter Posts Another Strong Quarter
  • Absorbable Hemostats Lead the Way
  • Progel’s Relaunch Pulls Up Biologic Sealants
  • Q419 US Hemostats and Sealants Events

All competitors posted gains for the quarter. Sealants continued their solid growth in Q419, with fibrin sealants in front. Absorbable hemostats led the US Hemostats market to an expansion of +4.4% in Q419.

Ethicon continued to lead the overall US Hemostat and Sealants market, amplifying its sales +3.6% YoY to $XXX Blurred in revenue with 43.9% market share, and augmenting its FY19 sales +4.3% to $XXX Blurred. Baxter’s investment in broadening its portfolio with the Mallinckrodt acquisition continued to pay off with a +8.8% YoY growth to $XXX Blurred revenue in Q419. However, SmartTRAK’s statistical analysis indicates that recent fluctuations in market share don’t signal any overall trends. 

Read the entire Q419/FY19 US Hemostats and Sealants Market Recap, including company revenues and shares, analysis, news, data and charts*...

*The entire article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.

Request SmartTRAK Subscription Info

 

Topics: Wound Care

Doug Devens
Written by Doug Devens

20 years of diverse medical device experience, including leading companies 3M, Coloplast and Boston Scientific, along with emerging companies. Leadership experience in product development, including championing the process for voice of customer and concept feedback sessions with key thought leaders.

    Recent Articles